TO ASSESS THE EFFECTIVENESS OF FIRST-LINE XELOX COMBINED WITH BEVACIZUMAB IN PATIENTS WITH STAGE IV COLORECTAL CANCER TREATED AT NGHE AN ONCOLOGY HOSPITAL. YHCĐ 2026, 67 (Số CĐ12- Bệnh viện Ung bướu Nghệ An). https://doi.org/10.52163/yhc.v67iCD12.6141.